Advertisement
Screener

PEPGEN INC. (PEPG) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PEPGEN INC. Cash Flow Breakdown

Cash flow breakdown shows where PEPGEN INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $81.64M went out.
  • Fiscal year ended 2025-12-31: from investing, $15.23M went out.
  • Fiscal year ended 2025-12-31: from financing, $107.98M came in.
  • Fiscal year ended 2025-12-31: change in cash, $11.09M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$81.64M-$15.23M$292.00K$107.69M*$11.09M
2024-12-31-$82.37M-$37.67M$9.90M$78.85M*-$31.35M
2023-12-31-$69.00M-$32.00M$253.00K-$100.90M
2022-12-31-$59.27M-$3.75M$114.27M-$2.07M*$48.86M
2021-12-31-$22.60M-$500.00K$147.66M*$124.59M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$15.81M*-$3.52M*$0.00*
2026-03-31-$18.43M-$1.46M$1.51M-$18.36M
2025-12-31-$15.85M*-$66.24M*$167.00K*
2025-09-30-$19.26M*$18.90M*$0.00*$108.05M*
2025-06-30-$23.60M*$14.96M*$0.00*
2025-03-31-$22.93M$17.15M$0.00-$5.79M
2024-12-31-$19.48M*$26.50M*$0.00*
2024-09-30-$24.01M*-$133.00K*$0.00*
2024-06-30-$16.35M*-$52.74M*$0.00*$1.33M*
2024-03-31-$22.53M-$11.29M$9.90M$77.07M*$53.08M
2023-12-31-$19.42M*-$29.59M*$38.00K*
2023-09-30-$16.68M*-$225.00K*$0.00*
2023-06-30-$17.47M*-$1.01M*$85.00K*
2023-03-31-$15.42M-$1.18M$130.00K-$16.35M
2022-12-31-$13.39M*-$1.10M*$0.00*
2022-09-30-$20.97M*-$430.00K*$0.00*-$1.42M*
2022-06-30-$12.64M*-$609.00K*$113.41M*
2022-03-31-$12.27M-$1.61M-$14.04M
2021-12-31-$5.99M*-$156.00K*-$1.03M*
2021-09-30-$7.65M*-$24.00K*$132.87M*
2021-06-30-$6.13M*-$15.00K*
2021-03-31-$2.83M-$305.00K-$3.11M

Similar stocks

Stock NameCountryMarket CapPE Ratio
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Nkarta, Inc. (NKTX)United States$0.205B-1.73
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39